Macrophage activation marker sCD163 correlates with accelerated lipolysis following LPS exposure: a human-randomised clinical trial
Background: Macrophage activation determined by levels of soluble sCD163 is associated with obesity, insulin resistance, diabetes mellitus type 2 (DM2) and non-alcoholic fatty liver disease (NAFLD). This suggests that macrophage activation is involved in the pathogenesis of conditions is characte...
Main Authors: | Nikolaj Rittig, Mads Svart, Niels Jessen, Niels Møller, Holger J Møller, Henning Grønbæk |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2018-01-01
|
Series: | Endocrine Connections |
Subjects: | |
Online Access: | http://www.endocrineconnections.com/content/7/1/107.full |
Similar Items
-
Systemic, but not local, low-grade endotoxinemia increases plasma sCD163 independently of the cortisol response
by: Ermina Bach, et al.
Published: (2019-02-01) -
Soluble CD163 correlates with lipid metabolic adaptations in type 1 diabetes patients during ketoacidosis
by: Mads Svart, et al.
Published: (2019-01-01) -
Relationship Between sCD163 and mCD163 and Their Implication in the Detection and Typing of Leprosy
by: Farag AGA, et al.
Published: (2020-06-01) -
Increased Serum Levels of sCD14 and sCD163 Indicate a Preponderant Role for Monocytes in COVID-19 Immunopathology
by: Jose Gómez-Rial, et al.
Published: (2020-09-01) -
Macrophage Activation Markers, CD163 and CD206, in Acute-on-Chronic Liver Failure
by: Marlene Christina Nielsen, et al.
Published: (2020-05-01)